Physician profile
Daniela Gamba
NPI 1003569237
$11,654.92
in general payments reported to CMS, 2019-2025
31 companies · $3,225 in 2025
The $3,225 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,290 · 2023: $3,456 · 2024: $2,684 · 2025: $3,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,923 · Consulting Fee: $1,350 · Education: $91.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,923.14 |
| Consulting Fee | $1,350.00 |
| Education | $91.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,723.92 | 2022-2025 | |
| Janssen Biotech, INC. | $2,087.38 | 2022-2025 | Tremfya, Stelara, Simponi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $687.81 | 2022-2025 | Trulance, Xifaxan |
| Genzyme Corporation | $584.44 | 2022-2025 | |
| Gilead Sciences, INC. | $507.27 | 2022-2024 | Epclusa |
| E.R. Squibb & Sons, L.L.C. | $500.24 | 2022-2023 | Zeposia |
| Celgene Corporation | $480.41 | 2022-2024 | Zeposia |
| Aimmune Therapeutics, INC. | $424.09 | 2024-2025 | Zenpep, Vowst |
| Regeneron Healthcare Solutions, INC. | $399.40 | 2022-2025 | Dupixent |
| Janssen Scientific Affairs, LLC | $307.38 | 2022-2023 | Stelara |
| Evoke Pharma, INC. | $302.08 | 2022-2023 | Gimoti |
| Intra-Sana Laboratories | $292.94 | 2022-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Ardelyx, INC. | $286.80 | 2023-2024 | Ibsrela |
| Lucid Diagnostics INC. | $270.92 | 2022-2024 | |
| Pfizer INC. | $215.92 | 2023-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $190.30 | 2022-2025 | Pancreaze |
| Amgen INC. | $184.04 | 2025 | Uplizna |
| Takeda Pharmaceuticals U.S.A., INC. | $157.40 | 2022-2025 | Entyvio, Gattex, Eohilia |
| Nestle Healthcare Nutrition INC. | $143.01 | 2022-2023 | |
| Madrigal Pharmaceuticals | $123.28 | 2024-2025 | Rezdiffra, Resmetirom |
| Celltrion USA INC. | $119.81 | 2024-2025 | Zymfentra, Vegzelma |
| Intercept Pharmaceuticals, INC. | $109.59 | 2022-2024 | Ocaliva |
| Merck Sharp & Dohme LLC | $108.29 | 2022-2023 | Dificid, Zinplava, Recarbrio |
| Phathom Pharmaceuticals, INC. | $101.95 | 2024-2025 | Voquezna |
| Redhill Biopharma INC. | $75.22 | 2022-2024 | Aemcolo, Talicia |
| Ipsen Biopharmaceuticals, INC | $58.82 | 2025 | Iqirvo |
| Lilly USA, LLC | $55.73 | 2024-2025 | Omvoh |
| Novo Nordisk INC | $54.45 | 2025 | Wegovy |
| Ironwood Pharmaceuticals, INC | $39.41 | 2023-2024 | Linzess |
| Axonics, INC. | $32.94 | 2022-2024 | Axonics |
| Alnylam Pharmaceuticals INC. | $29.68 | 2025 | Givlaari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Gamba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.